The global non-invasive brain trauma monitoring devices market size is expected to reach USD 24.8 billion by 2030, registering to grow at a CAGR of 8.6% from 2024 to 2030 according to a new report by Grand View Research, Inc. The rising burden of Traumatic Brain Injuries (TBI) is a leading cause of neurodegenerative disorders such as Alzheimer’s and Parkinson’s disease. As a result, there are numerous initiatives taken at the regional and global levels to create awareness, which facilitated a heavy diagnosis rate, thus governing the growth of non-invasive brain trauma monitoring devices.
Technological advancements in this field are connected with accuracy, portability, and affordability, which are supporting the industry growth. For instance, recently available non-invasive intracranial pressure monitors, such as Transcranial Doppler (TCD), are accurate in positioning and creating a better pressure gradient and also bringing in more accuracy in the treatment.
The Minimally Invasive Surgeries (MIS) are less traumatic to patients and facilitate faster recovery with minimum complications. In minimally invasive neurological surgeries, non-invasive brain trauma monitoring devices play a critical role. Thus, the increasing volume of MIS is driving the industry’s growth.
The key target population in this industry includes people above 60 years. This section of the population is at a greater risk for TBIs and their co-morbidities. The global geriatric population is on arise and is a vital driver for this industry.
Monitoring devices that include intracranial pressure monitors, MRI scanners, CT scanners, PET scanners, EEG, and MEG held a substantial share of around 63.2% in 2023. The high costs associated with this equipment and the increasing usage of these devices governed the growth of this segment.
The consumables sub-segment in the product segment is anticipated to witness lucrative growth over the forecast period. The repeat purchase of consumables and regular maintenance activities are expected to spur the demand for these products.
The market on the basis of end-use is segmented into hospitals, neurological centers, and other settings. The hospital segment dominated the end-use segment with over 80.9% of the revenue. The greater volume of surgeries performed in hospitals contributed to its growth.
North America dominated the non-invasive brain trauma monitoring devices market in 2023. The advanced healthcare system, high awareness level, and well-planned reimbursement policies helped this market to grow in this region. However, Asia Pacific is anticipated to witness significant growth over the forecast period.
Some key players operating in this industry include Advanced Brain Monitoring, Inc.; Cadwell Industries, Inc.; Canon Medical Systems Corporation; Compumedics Ltd.; Magstim EGI; General Electric Company; Hitachi, Ltd.; Koninklijke Philips N.V.; Medtronic; Natus Medical Incorporated; NeuroLogica Corp.; NeuroWave Systems, Inc., are the key initiatives in this industry.
Please note The report will be delivered in 2-3 business days upon order notification.